• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Compliance
  • UAMS Health
  • Jobs
  • Giving
  • Compliance Education Program
    • Advanced Certified Research Specialist Program
      • Advanced Certified Research Specialist Program Requirements
      • Advanced Certified Research Specialist Registration
    • Certified Research Specialist Program
      • Bonny Hope Wallace Award for Excellence in Human Subject Research
      • Certified Research Specialist Program Proficiency Exam
      • Certified Research Specialist Program Registration
      • Certified Research Specialist Program Requirements
      • Maintaining Certification
    • Educational Resources
    • Forms
      • General Information About the Certified Research Specialist Program
    • Good Clinical Practice Training
    • HIPAA Training
    • Human Subject Protection Training (CITI)
    • Responsible Conduct of Research Training
    • Upcoming Advanced Certified Research Specialist Courses
    • Upcoming Certified Research Specialist Courses
  • Resources and Tools
    • Non-Human Research Use of DEA Controlled Substances
    • Setting Up Studies and/or Research Staff
      • Human Subject Protection Training (CITI)
    • Tools and Templates
      • Regulatory Binders
      • Subject Study File and Source Documentation
  • Compliance Reviews
    • New Investigation Consult and Education Reviews
    • Selection for Review
    • The Review Process
  • Reporting Research Concerns
    • Compliance Hotline FAQs
    • Research Misconduct
  • News
  • Contact Us
  • Helpful Links
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Office of Research Compliance
  4. News
  5. Page 3

News

ORI: NIH Fellow Falsified Dozens of Figures in Two Published Papers

In its first research misconduct finding of 2018, the HHS Office of Research Integrity (ORI) announced that Colleen Skau committed research misconduct when she was a postdoctoral fellow at the National Heart, Lung, and Blood Institute. In a 2/19/18 announcement posted on its website, ORI said Skau falsified, fabricated and otherwise skewed data in dozens […]

Read More

Filed Under: News

Federal Policy for the Protection of Human Subjects

On January 17,  the U.S. Department of Health and Human Services and 15 other federal departments issued an interim final rule to delay the implementation of the revised Federal Policy for the Protection of Human Subjects (“Common Rule”) for six months, until July 19, 2018 to provide regulated entities additional time to make the necessary […]

Read More

Filed Under: News

Admission Leads to First ORI Misconduct Finding in 10 Months

Eleven figures in a 2016 paper were fabricated or falsified by a former NIH “research training awardee” who admitted to the misconduct and agreed to a three-year supervisory plan should she receive HHS research support in the future, according to a notice in the June 20 Federal Register. The HHS Office of Research Integrity (ORI) […]

Read More

Filed Under: News

ICMJE Announces Requirement for Clinical Trial Data Sharing Statements

At the link below is a proposed policy published in 2016, ICMJE today announced its requirements for data sharing in the near future (attached). Key points: As of 1 July 2018 manuscripts submitted to ICMJE journals that report the results of clinical trials must contain a data sharing statement Clinical trials that begin enrolling participants […]

Read More

Filed Under: News

FDA Issues Warning Letter to UC San Diego Ophthalmology Prof

The Food and Drug Administration (FDA) found numerous “objectionable conditions” during an inspection last summer of research conducted by Kang Zhang, professor of ophthalmology and chief of ophthalmic genetics at University of California San Diego, the agency said in a Jan. 5 “warning letter” recently posted online. “[W]e conclude that you did not adhere to […]

Read More

Filed Under: News

ORI Finds Former PostDoc Fellow Engaged in Research Misconduct

Andrew R. Cullinane, Ph.D., National Institutes of Health:  Based on Respondent’s admission, an assessment conducted by the National Institutes of Health (NIH), and analysis conducted by ORI in its oversight review, ORI found that Dr. Andrew R. Cullinane, former postdoctoral fellow, Medical Genetics Branch, National Human Genome Research Institute (NHGRI), NIH, engaged in research misconduct […]

Read More

Filed Under: News

A Top N.Y.U. Researcher Dismissed from Research Study

Alexander Neumeister, M.D., former head of the molecular imaging program at New York University (NYU) School of Medicine, conducted psychiatric research without providing appropriate oversight, states a Feb. 6 warning letter issued by the Food and Drug Administration (FDA), which cited a host of problems uncovered in two protocols during an inspection from July 16-Aug. […]

Read More

Filed Under: News

ORI Finds Investigator Committed Misconduct at Two Institutions

The HHS Office of Research Integrity (ORI) has entered into a voluntary settlement agreement calling for the supervision of a researcher found to have committed misconduct at two different universities over a six-year period. In a May 24 notice on its website, ORI said Ricky Malhotra committed the misconduct while a research assistant professor in […]

Read More

Filed Under: News

ORI Finds Two Committed Research Misconduct

A researcher has agreed to a five-year debarment for misconduct while another’s work, if involving Public Health Service (PHS) support, will be supervised for three years, according to the HHS Office of Research Integrity (ORI). The debarment was agreed to by John Pastorino, an associate professor in the Department of Molecular Biology at Rowan University […]

Read More

Filed Under: News

FDA: Accept Human-focused Preclinical Tests to Improve Drug Safety

Patient deaths halted at least two pharmaceutical clinical trials in the last two months. The good news is, Robert Califf, M.D., who was confirmed by the Senate last week as commissioner of the Food and Drug Administration, has an opportunity to address this issue. In his new role, Dr. Califf is in a position to […]

Read More

Filed Under: News

  • «Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Next Page»
University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences